⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17043 | 0.68 | — | — | |
| SCHEMBL2456554 | 0.67 | — | — | |
| SCHEMBL111715 | 0.65 | — | — | |
| SCHEMBL88159 | 0.59 | — | — | |
| SCHEMBL13505442 | 0.59 | — | — | |
| SCHEMBL16269738 | 0.57 | — | — | |
| SCHEMBL184102 | 0.57 | — | — | |
| SCHEMBL18741054 | 0.55 | LMNA (0.44) | — | |
| SCHEMBL293764 | 0.55 | — | — | |
| SCHEMBL12808541 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117777185-A | Singlet oxygen response phospholipid-fluorescence quenching group coupled molecule, up-conversion luminescence nano probe and preparation method and application thereof | 湖南大学 | 2024-03-29 | — | — | CN | disclosed |
| EP-4188917-A1 | PREPARATION OF ERDOSTEINE OR A DERIVATIVE THEREOF USING A CONTINUOUS FLOW PROCESS | EDMOND PHARMA S.R.L. (IT) | 2023-06-07 | — | — | EP | disclosed |
| WO-2022023929-A1 | PREPARATION OF ERDOSTEINE OR A DERIVATIVE THEREOF USING A CONTINUOUS FLOW PROCESS | EDMOND PHARMA S.R.L. (IT) | 2022-02-03 | — | — | WO | disclosed |
| WO-2014028322-A1 | MODULATORS OF THE HISTAMINE H3 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2014-02-20 | — | — | WO | disclosed |
| WO-2013151982-A1 | METHODS AND COMPOUNDS USEFUL IN TREATING PRURITUS, AND METHODS FOR IDENTIFYING SUCH COMPOUNDS | ARENA PHARMACEUTICALS, INC. (US) | 2013-10-10 | — | — | WO | disclosed |
| WO-2013026455-A1 | PERMANENTLY POSITIVELY CHARGED ANTIDEPRESSANTS | AARHUS UNIVERSITET (DK) | 2013-02-28 | — | — | WO | disclosed |
| US-20110301288-A1 | THIOIC ACIDS AS BUILDING BLOCK FOR POLYTHIOESTERS | DSM IP ASSETS B.V. (NL) | 2011-12-08 | — | — | US | disclosed |
| EP-2358668-A1 | THIOIC ACIDS AS BUILDING BLOCK FOR POLYTHIOESTERS | DSM IP Assets B.V. (NL) | 2011-08-24 | — | — | EP | disclosed |
| WO-2010070132-A1 | THIOIC ACIDS AS BUILDING BLOCK FOR POLYTHIOESTERS | DSM IP ASSETS B.V. (NL) | 2010-06-24 | — | — | WO | disclosed |
| EP-2199281-A1 | Thioic acids as building block for polythioesters | DSM IP Assets B.V. (NL) | 2010-06-23 | — | — | EP | disclosed |
| EP-2051978-A2 | ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Arena Pharmaceuticals, Inc. (US) | 2009-04-29 | — | — | EP | disclosed |
| EP-2035435-A1 | NOVEL LAPACHONE COMPOUNDS AND METHODS OF USE THEREOF | ARQULE, INC. (US) | 2009-03-18 | — | — | EP | disclosed |
| WO-2007139569-A1 | NOVEL LAPACHONE COMPOUNDS AND METHODS OF USE THEREOF | ARQULE, INC. (US) | 2007-12-06 | — | — | WO | disclosed |
| WO-2007136875-A2 | ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2007-11-29 | — | — | WO | disclosed |